Literature DB >> 16847574

Stability analysis of the bacteriophage phiKMV lysin gp36C and its putative role during infection.

Y Briers1, R Lavigne, P Plessers, K Hertveldt, I Hanssens, Y Engelborghs, G Volckaert.   

Abstract

The kinetic, thermodynamic and structural stability of gp36C, the virion-associated peptidoglycan hydrolase domain of bacteriophage phiKMV, is analyzed. Recombinant gp36C is highly thermoresistant (k = 0.595 h(-1) at 95 degrees C), but not thermostable (T(m) = 50.2 degrees C, DeltaH(cal) = 6.86 x 10(4) cal mol(-1)). However, aggregation influences kinetic stability in an unusual manner since aggregation is more pronounced at 55 degrees C than at higher temperatures. Furthermore, gp36C reversibly unfolds in a two-state endothermic transition, and circular dichroism analysis shows that gp36C almost completely refolds after a 3-h heat treatment at 85 degrees C. These properties are in agreement with gp36C being part of the extensible tail which is ejected in an unfolded state during phage infection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16847574     DOI: 10.1007/s00018-006-6183-7

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  9 in total

1.  Structural analysis of bacteriophage-encoded peptidoglycan hydrolase domain KMV36C: crystallization and preliminary X-ray diffraction.

Authors:  Kristof Van Hecke; Yves Briers; Rita Derua; Etienne Waelkens; Rob Lavigne; Luc Van Meervelt
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2008-03-21

2.  Characterization of modular bacteriophage endolysins from Myoviridae phages OBP, 201φ2-1 and PVP-SE1.

Authors:  Maarten Walmagh; Yves Briers; Silvio Branco dos Santos; Joana Azeredo; Rob Lavigne
Journal:  PLoS One       Date:  2012-05-15       Impact factor: 3.240

3.  The T7-related Pseudomonas putida phage φ15 displays virion-associated biofilm degradation properties.

Authors:  Anneleen Cornelissen; Pieter-Jan Ceyssens; Jeroen T'Syen; Helena Van Praet; Jean-Paul Noben; Olga V Shaburova; Victor N Krylov; Guido Volckaert; Rob Lavigne
Journal:  PLoS One       Date:  2011-04-19       Impact factor: 3.240

Review 4.  Bacteriophages and phage-derived proteins--application approaches.

Authors:  Zuzanna Drulis-Kawa; Grazyna Majkowska-Skrobek; Barbara Maciejewska
Journal:  Curr Med Chem       Date:  2015       Impact factor: 4.530

5.  Biochemical Characterization and Validation of a Catalytic Site of a Highly Thermostable Ts2631 Endolysin from the Thermus scotoductus Phage vB_Tsc2631.

Authors:  Magdalena Plotka; Anna-Karina Kaczorowska; Agnieszka Morzywolek; Joanna Makowska; Lukasz P Kozlowski; Audur Thorisdottir; Sigurlaug Skírnisdottir; Sigridur Hjörleifsdottir; Olafur H Fridjonsson; Gudmundur O Hreggvidsson; Jakob K Kristjansson; Slawomir Dabrowski; Janusz M Bujnicki; Tadeusz Kaczorowski
Journal:  PLoS One       Date:  2015-09-16       Impact factor: 3.240

Review 6.  Bacteriophage-encoded virion-associated enzymes to overcome the carbohydrate barriers during the infection process.

Authors:  Agnieszka Latka; Barbara Maciejewska; Grazyna Majkowska-Skrobek; Yves Briers; Zuzanna Drulis-Kawa
Journal:  Appl Microbiol Biotechnol       Date:  2017-03-23       Impact factor: 4.813

Review 7.  Phage-Derived Peptidoglycan Degrading Enzymes: Challenges and Future Prospects for In Vivo Therapy.

Authors:  Hugo Oliveira; Carlos São-José; Joana Azeredo
Journal:  Viruses       Date:  2018-05-29       Impact factor: 5.048

8.  Endemic bacteriophages: a cautionary tale for evaluation of bacteriophage therapy and other interventions for infection control in animals.

Authors:  Andrew M Kropinski; Erika J Lingohr; Dianne M Moyles; Shivani Ojha; Amanda Mazzocco; Yi-Min She; Susan J Bach; Erica A Rozema; Kim Stanford; Tim A McAllister; Roger P Johnson
Journal:  Virol J       Date:  2012-09-17       Impact factor: 4.099

9.  A VersaTile-driven platform for rapid hit-to-lead development of engineered lysins.

Authors:  H Gerstmans; D Grimon; D Gutiérrez; C Lood; A Rodríguez; V van Noort; J Lammertyn; R Lavigne; Y Briers
Journal:  Sci Adv       Date:  2020-06-03       Impact factor: 14.136

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.